Skin Mycobiome of Psoriasis Patients is Retained during Treatment with TNF and IL-17 Inhibitors

Background: Biological treatment relieves refractory skin lesions in patients with psoriasis; however, changes in the fungal microbiome (the mycobiome) on the skin are unclear. Methods: The skin mycobiome of psoriasis patients treated with TNF inhibitors (TNFi, n = 5) and IL-17 inhibitors (IL-17i, n...

Descripción completa

Detalles Bibliográficos
Autores principales: Koike, Yuta, Kuwatsuka, Sayaka, Nishimoto, Katsutaro, Motooka, Daisuke, Murota, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312082/
https://www.ncbi.nlm.nih.gov/pubmed/32486022
http://dx.doi.org/10.3390/ijms21113892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312082/
https://www.ncbi.nlm.nih.gov/pubmed/32486022
http://dx.doi.org/10.3390/ijms21113892

Ejemplares similares